ReviewTherapeutic advances in chronic disease2022

Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review.

Yimeng Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.